Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...

The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

Robert F. Kennedy Jr. continues his anti-vax crusade by cancelling million-dollar bird flu vaccine deal with Moderna.

The shot is also cleared for individuals between 12 and 64 years of age who are at least one risk factor as defined by the ...